Delivery Order HHSD200201461269I-HHSD2002014612690001
Award Date 5/13/15
Potential Completion Date 6/30/17
Potential Value $178K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hampstead, MD 21074, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $299,776.70 firm fixed-price delivery order contract to Translational Technologies International, LLC for rapid evaluations of lifestyle intervention programs related to hypertension and cardiovascular health. The contract was awarded on September 15, 2018 with a completion date of March 14, 2020. The contract was not set aside for a specific business type. Translational Technologies International,...
- This is a federal contract for TECHNICAL AND MANAGEMENT SUPPORT SERVICES (TAMS) awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Translational Technologies International, LLC (TTI Research), a small disadvantaged and woman-owned business. The contract has a potential value of $164,840.00 and is a Delivery Order under the larger Technical and Management Support for Health Promotion Activities indefinite-delivery, indefinite-quantity (IDIQ)...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $249,072.07 firm fixed-price delivery order contract to Translational Technologies International, LLC (TTI Research) for the "Rigorous Evaluation of Health Equity Strategies to Address Heart Disease and Stroke Prevention." This contract is a task order under the broader "Technical and Management Support for Health Promotion Activities" indefinite-delivery, indefinite-quantity...
- <p>This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Public Health Partners, LLC, a woman-owned small business, for the development of tools and resources addressing heart disease and stroke. The contract has a ceiling value of $99,589.00 and a period of performance ending on September 29, 2018. The contract is not associated with a larger vehicle and does not have a set-aside designation.</p>
- This is a $136,300.00 firm fixed-price delivery order contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to the prime contractor IHRC, Incorporated. The contract is for technical and professional assistance for DPDM, with a period of performance from July 6, 2017 to July 5, 2018. IHRC is a self-certified small disadvantaged, woman-owned small business that specializes in providing a range of services to HHS agencies, including...
- This is a Firm Fixed Price delivery order issued by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Carter Consulting, Inc., a minority-owned, for-profit business, to provide information technology support services. The contract is part of the larger CDC Information Management Support 2010 - 2021 Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The total potential value of this award is $1,977,542.69, and the period of performance...
- This is a $643,374,029.78 Delivery Order contract awarded by the Centers for Disease Control and Prevention (CDC) to DB Consulting Group, Inc., a woman-owned small business. The contract is for Information Management (IM) services support for the National Center for Health Marketing. It is a Time and Materials contract under the CDC Information Management Support 2010 - 2021 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract does not have a set-aside designation and...
- This is a firm fixed-price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Ihrc, Incorporated, a self-certified small disadvantaged, woman-owned business. The contract, with a ceiling value of $725,916.10, is for technical and professional assistance related to disease prevention and detection management (DPDM). The contract period of performance runs from August 31, 2016 to September 2, 2018. Ihrc has extensive experience providing a range of...
- This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Communicatehealth Inc., a woman-owned small business, for communication support services. The contract has a potential value of $183,040.81 and a completion date of September 8, 2023. It was issued under the Urgent and Emerging Communication Support Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. Communicatehealth...
- This is a $25,000 cost-plus-fixed-fee delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Massgenics Inc., a minority-owned management consulting firm that specializes in providing international technical, operational, and professional support services. The contract is part of the CDC's ITOPSS 4.0 program, a multiple-award Indefinite Delivery Contract (IDC) with a $45 million ceiling that enables the CDC to quickly issue task orders for global health...
- HHSD200201461269IIndefinite Delivery Contract
- HHSD200201461269I-HHSD2002014612690001Delivery Order
This is a firm fixed-price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Translational Technologies International, LLC, a small disadvantaged and woman-owned limited liability company. The contract is part of the Technical and Management Support for Health Promotion Activities indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The purpose of this $178,118 contract is to assess the cost-effectiveness of hypertension management in chronic kidney disease. There is no set-aside designation associated with this award. The contract has a period of performance ending on June 30, 2017.
Generated 4/2/25, 9:18 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 4 | Other Administrative Action | $0 | 1/27/22 | |
| 2 | Change Order | $0 | 2/17/17 | |
| 1 | Other Administrative Action | $0 | 10/14/15 | |
| Not listed | Not listed | $178.1k | 5/19/15 |